How do PARP inhibitors work?
PARP inhibitors are a type of cancer drug. PARP stands for poly adenosine diphosphate-ribose polymerase, a type of enzyme that helps repair DNA damage in cells. PARP inhibitors work by preventing cancer cells from repairing, allowing them to die. These drugs are a type of targeted therapy.
How does PARP inhibitor work in ovarian cancer?
Poly ADP-ribose polymerase 1 (PARP-1) inhibitors work by stopping cancer cells with damaged DNA from repairing themselves and replicating – thus reducing the risk of recurrence after HRD- or BRCA-associated ovarian cancer by 40-70%.
How do PARP inhibitors induce synthetic lethality?
It is suggested that PARP inhibitors cause an increase in DNA single‐strand breaks (SSBs), which are converted during replication to irreparable toxic DNA double‐strand breaks (DSBs) in BRCA1/2 defective cells.
What does the PARP enzyme do?
PARP is a critical enzyme involved in DNA repair and many other cellular processes including transcription and modulation of chromatin structure. PARP plays a central role in NER and BER, and enables repair of DNA damage caused by alkylating agents and chemotherapeutic drugs.
What class of drugs are PARP inhibitors?
Antineoplastic poly adenosine diphosphate-ribose polymerase (PARP) inhibitors are a class of drugs used to treat breast cancer, prostate cancer, ovarian cancer, fallopian tube (the tube that transports eggs released by the ovaries to the uterus), and peritoneal (layer of tissue that lines the abdomen) cancer in people …
What is PARP inhibitor resistance?
Acquired resistance to poly(ADP-ribose) polymerase (PARP) inhibitors often occurs through loss of additional DNA damage proteins, often resulting in the emergence of novel vulnerabilities that can be exploited therapeutically.
What is PARP pathway?
PARP1 acts as a first responder that detects DNA damage and then facilitates choice of repair pathway. PARP1 contributes to repair efficiency by ADP-ribosylation of histones leading to decompaction of chromatin structure, and by interacting with and modifying multiple DNA repair factors.